Gensaic logo

Gensaic jobs and careers

United States

About Gensaic

Gensaic combines AI-powered protein design with unbiased directed evolution to develop tissue-selective ligands for targeted intracellular therapeutic delivery. The company's portfolio advances therapies for metabolic and age-related diseases, with an initial focus on siRNA payloads. FORGE™, Gensaic's proprietary product engine, integrates phage display for unbiased protein evolution within a generative AI architecture to discover and optimize protein molecules with enhanced tissue selectivity and drug-like properties. Founded through MIT and based in Cambridge, Massachusetts, Gensaic's team of physicians, bioengineers, and machine learning scientists is advancing a singular objective: to enable selective delivery of any therapeutic payload to any tissue of interest. For more information, please visit gensaic.com.

Founded in 2021 by Lavi Erisson.

Founded
2021
Employees
11 to 50
Total funding
$3.5M
Headquarters
United States

Leadership

The top of Gensaic's org chart, with how many people report into each leader.

LEPhoto of Lavi Erisson

Lavi Erisson

CEO and Co-Founder